Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,676,400 | 1,644,500 | 1,224,600 | 1,132,300 | 1,410,100 |
| Marketable Securities | 769,700 | 345,300 | 473,000 | 500,500 | 453,800 |
| Receivables | 811,500 | 834,400 | 876,900 | 828,100 | 802,100 |
| Inventories | 1,104,200 | 1,024,700 | 1,207,300 | 903,500 | 1,032,400 |
| Other current assets | 251,000 | 556,900 | 250,600 | 542,500 | 235,800 |
| TOTAL | $6,727,700 | $4,516,000 | $4,170,500 | $4,035,700 | $4,067,500 |
| Non-Current Assets | |||||
| PPE Net | 1,675,700 | 1,640,100 | 1,767,900 | 1,591,000 | 1,681,300 |
| Investments And Advances | 319,600 | 353,300 | 455,600 | 583,900 | 704,600 |
| Intangibles | 2,561,400 | 1,568,100 | 1,699,600 | 1,544,500 | 1,727,200 |
| Other Non-Current Assets | 1,686,800 | 2,021,800 | 1,642,700 | 1,608,100 | 1,190,199 |
| TOTAL | $6,243,500 | $5,583,300 | $5,565,800 | $5,327,500 | $5,303,299 |
| Total Assets | $12,971,200 | $10,099,300 | $9,736,300 | $9,363,200 | $9,370,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 172,800 | 185,900 | 212,300 | 186,600 | 190,600 |
| Accrued Expenses | 1,745,300 | 902,400 | 873,700 | 856,400 | 1,024,000 |
| TOTAL | $1,944,100 | $1,217,000 | $1,110,800 | $1,195,400 | $1,238,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 597,500 | 597,300 | 597,200 | 597,000 | 596,800 |
| aiOther Non-Current Liabilities | 819,600 | 781,700 | 842,800 | 851,600 | 809,200 |
| TOTAL | $1,415,700 | $1,377,700 | $1,439,100 | $1,448,400 | $1,404,800 |
| Total Liabilities | $3,359,800 | $2,594,700 | $2,549,900 | $2,643,800 | $2,643,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 589,800 | 602,400 | 602,600 | 601,300 | 606,500 |
| Common Shares | 654,300 | 653,500 | 651,800 | 650,500 | 649,900 |
| Retained earnings | 12,781,400 | 9,710,600 | 9,344,300 | 8,992,400 | 8,622,500 |
| Other shareholders' equity | -186,400 | -152,800 | -164,500 | -172,900 | -180,600 |
| TOTAL | $9,611,400 | $7,504,600 | $7,186,400 | $6,719,400 | $6,727,100 |
| Total Liabilities And Equity | $12,971,200 | $10,099,300 | $9,736,300 | $9,363,200 | $9,370,800 |